How do I know if probiotics will help or hurt my health?
UC expert featured in National Geographic article
The University of Cincinnati Cancer Center's Rekha Chaudhary was featured in a National Geographic article discussing groups of people that should stay away from taking probiotic supplements.
Probiotic supplements have become more popular and touted as a miracle cure for digestive issues, mental health ailments and hormonal imbalances, but some populations like cancer patients and those who are immunocompromised can be hurt rather than helped by the supplements.
Chaudhary explained cancer patients undergoing immunotherapy could experience negative outcomes after taking probiotics. Having a wide variety of bacteria in the microbiome seems to correlate with health and wellbeing.
“But probiotics are like the lionfish of the sea,” said Chaudhary, MD, adjunct professor in UC's College of Medicine and a Cancer Center integrative oncologist. “They're an invasive, destructive species and your microbiome diversity can go markedly down when you take probiotic [supplements].”
Over-the-counter probiotics are helpful for specific situations, like infectious diarrhea, Chaudhary said. But overall the promise of these supplements has not lived up to their reality yet.
Read the National Geographic article.
Featured photo at top of probiotic bacteria. Photo/Anusorn Nakdee/iStock Photo.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.